ROBERT SHARPE: Open Payments
NPI 1467733550 · NEW YORK MILLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 28 payments from 4 companies in 2025. Trend: 2023 $1,016 · 2024 $883 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $324 |
| ABBVIE INC. | 3 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Lundbeck LLC | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, SPRAVATO, REXULTI.
Industry payments across NY — which companies pay providers there.
